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Abstract 
A series of six coordinate homoleptic and heteroleptic Cr(III) complexes have been 
formed that incorporate 8-quinolinato ligands. Three classes of complex have been 
synthesised and characterised: (i) [Cr(Q)3]; (ii) [Cr(Q)2(H2O)2]Cl; (iii) 
[Cr(Q)(N^N)2](PF6)2 (where Q is a ligand, 8-hydroxyquinoline, 8-hydroxy-2-methyl-
quinoline, or 8-hydroxy-5-nitroquinoline; N^N = 1,10-phenanthroline or 2,2’-
bipyridine). Single crystal X-ray structures were obtained for four complexes giving 
examples of [Cr(Q)2(H2O)2]Cl, two [Cr(Q)(bipy)2](PF6)2 and [Cr(Q)(phen)2](PF6)2. Each 
complex shows the ligands in the expected coordination mode with a distorted 
octahedral geometry evident at the metal centre. The UV-vis. absorption data allowed 
assignments of the quinolinato-centred electronic transitions together with a much 
weaker spin allowed d-d transition (4A2→4T2) around 550 nm. Each complex was 
found to be luminescent in aerated MeCN solution at room temperature, which was 
attributed to a ligand-centred fluorescence based on the coordinated quinolinato 
ligand. 
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Introduction 
Coordination complexes of Cr(III) continue to stimulate interest and investigation. In 
particular, the electronic properties of octahedral complexes of Cr(III) have been 
investigated in a number of contexts, including luminescence, photoredox catalysis, 
and solar cells.1 In fact the photophysics and photochemistry of polypyridyl complexes 
of Cr(III) has been known for several decades2 and continues to drive interest in these 
compounds. A detailed understanding of the excited state electronic configurations 
(particularly the ordering of the 4T2 and 2E/2T1 excited states) of Cr(III) can allow the 
design of  complexes for a variety of application. For example the use of a very strong 
field ligand N,N’-dimethyl-N,N’-dipyridine-2-ylpyridine-2,6-diamine yields a water 
soluble near-IR luminescent Cr(III) complex, which may have application in biological 
imaging and sensing.3  Recent studies have also shown that relatively simple Cr(III) 
complexes of 1,10-phenanthroline and 2,2’-bipyridine type ligands may have 
application in the design of non-volatile memory device materials.4 Herein we report 
our investigations into a series of Cr(III) complexes that incorporate 8-quinolinato type 
ligands within the coordination sphere, including mixed ligand variants.  
 The coordination chemistry of 8-hydroxyquinoline (often referred to as ‘oxine’) 
is extremely well known and dates back many decades. Historically it has found 
important uses in analytical chemistry and separation techniques,5 and luminescent 
coordination compounds.6 More recent developments have included its utility in the 
development of supramolecular chemistry where its coordination chemistry and 
molecular recognition features can be exploited.7 Further interest in 8-
hydroxyquinoline has been stimulated by its use in medicinal chemistry,8 and as a 
chelating species in the development of potential radioimaging agents based upon 
Ga-68,9 In-111,10 Zr-8911 and, most recently, Mn-52.12  
 Complexes of 8-hydroxyquinoline with Cr(III) have been reported,13 although it 
is only recently that the structural, spectral and electrochemical properties of [Cr(Q)3] 
(where Q = 8-quinolinato) have been described in detail.14 Consequently, examples of 
mixed ligand systems of Cr(III) which incorporate 8-quinolinato chelates appear to be 
quite rare. The current study includes structural, analytical and spectroscopic 
characterisation of these new Cr(III) complexes, including luminescence properties.   
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Results and discussion 
Synthesis of the complexes  
Three types of Cr(III) complex (Scheme 1) were synthesised that incorporate 8-
quinolinato (Q) ligands: homoleptic [Cr(Q)3], bis aquo species [Cr(Q)2(H2O)2]Cl, and 
mixed ligand [Cr(Q)(N^N)2](PF6)2 (where Q = quinolinato ligand, and N^N = 1,10-
phenanthroline or 2,2’-bipyridine). [Cr(Q)2(H2O)2]Cl complexes were synthesised by 
heating CrCl3.6H2O and two equivalents of a 8-hydroxyquinoline ligand in ethanol/H2O 
to reflux for three hours; the ligand variants were 8-hydroxyquinoline (HQ), 2-methyl-
8-hydroxyquinoline (MeHQ) and 5-nitro-8-hydroxyquinoline (NO2HQ). The [Cr(Q)3] 
species were obtained in a similar manner using three equivalents of ligand. The 
heteroleptic [Cr(Q)(N^N)2](PF6)2 complexes were synthesised by stirring the 
appropriate precursor species [Cr(N^N)2(CF3SO3)2](CF3SO3) with the HQ ligand in 
acetonitrile at room temperature for 12 hours. Excess KPF6 was then added to induce 
precipitation of the products. The yields for all complexations were between 57-80%, 
and air and moisture-stable solids were obtained in all cases. The complete series of 
synthesised complexes is represented in Scheme 1. 
 
 
Scheme 1. The Cr(III) coordination complexes synthesised in this study. 
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X-ray crystallographic studies 
All crystals were grown using vapour diffusion techniques. Data collection parameters 
are presented in Table 1, and all key bond lengths and bond angles that describe the 
coordination spheres are presented in subsequent Tables 2-5. 
Table 1. Crystallographic data for compounds [Cr(MeQ)2(H2O)2]Cl.3/2H2O (1),  
[Cr(Q)(phen)2](PF6)2.MeCN (2),  [Cr(MeQ)(bipy)2](PF6)2.H2O (3) and 
[Cr(NO2Q)(bipy)2](PF6)2.2MeCN (4). 
Compound 1 2 3 4 
 
Chemical 
 Formula 
C20H23ClCrN2 
O5.50 
C35H25CrF12N6 O 
P2 
C30H26CrF12N5 
O2 P2 
C33H27CrF12N8      
O3 P2 
Mr. g.mol-1 466.85 887.55 830.50 925.56 
Crystal  
system  
Triclinic Triclinic Monoclinic 
 
Triclinic 
Space 
group  
P-1 P-1 P21/n P-1 
T(K) 100(2) 100(2) 100(2) 100(2) 
a, Å 12.0329(3) 10.3602(3) 10.0830(3) 9.7304(3) 
b, Å 12.1647(3) 12.7649(3) 14.2406(3) 12.3923(5) 
c, Å 14.9310(4) 14.7897(4) 23.9077(6) 17.3417(4) 
a, degree 88.506(2) 101.265(2) 90° 107.519(3)° 
b, degree 84.436(2) 96.942(2) 101.734(3)° 95.633(2)° 
g, degree 82.002(2) 111.499(2) 90° 109.667(3)° 
Z 4 2 4 2 
Dc. Mg/m3 1.440  1.690 1.641 1.679 
µ(MO K a),  
mm-1 
0.691  
 
0.526 0.541 0.510 
Reflections 
collected 
17846 26044 37009 30575 
 
Unique 
 reflections 
17846 7986 7707 8377 
Rint 0 0.0209 0.0290 0.0265 
R1[I>2σ<(I)] 0.0784 0.0350 0.0448 0.0626 
wR2(all 
data) 
0.1762 0.0933 0.1228 0.1821 
CCDC: 1865072 1865075 1865074 1865073 
Crystal structure of [Cr(MeQ)2(H2O)2]Cl.3/2H2O 
[Cr(MeQ)2(H2O)2]Cl.3/2H2O crystallises in the triclinic space group P-1. There are 2 
independent Cr(III) complexes within the asymmetric unit that are similar thus only one 
is described below. The Cr(III) cation lies at the centre of a slightly distorted octahedral 
coordination sphere. The two bidentate MeQ ligands are arranged so that the oxygen 
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donors are trans to one another, and the nitrogens are cis; the two water molecules 
are in a mutually cis arrangement (Figure 1a-c).  The Cr-O41 and Cr-O42 bond lengths 
(Table 2) relate to the coordinated water molecules and are longer than those found 
for Cr-O1 and Cr-O11. The Cr-O coordinative bond lengths range from 1.923(3) to 
1.986(3) Å, and the Cr-N bond lengths are significantly longer and range from 2.096(4) 
to 2.100(4) Å. It is typical in Cr(III) complexes coordinated by six donor atoms (2N, 2O 
and 2O from two H2O molecules) that the bond length of Cr-O is shorter than Cr-N, 
and Cr-O shorter than Cr-OH2: the Cr-O distances range from 1.917-1.958, and Cr-
OH2 distances range from 1.982-2.006 Å and Cr-N range from 2.030-2.067 Å.15 The 
bond angles O11-Cr1-O1 and O42-Cr1-N11 are 172.45(14)º and 167.57(15)º 
respectively (Table 2). The pyridyl ring in each quinolinato ligand is nearly 
perpendicular to the other MeQ molecule (N11-Cr1-N1 91.94(15)º). Two 
intermolecular hydrogen bonds are observed between the hydrogen atom in the 
coordinated water and the chloride ion (O42-H42A...Cl1 at 2.21 Å), and between the 
hydrogen atom of the same coordinated water molecule and the oxygen atom in the 
uncoordinated water (O42-H42B...O45i and the bond length is 1.72 Å). Furthermore, 
the uncoordinated water molecule H-bonds with the oxygen atom of the MeQ ligand 
(O45-H45B...O11, the bond length is 1.95 Å).  
 
 
 
 
 
 
 
 
 
Figure 1a. Structural representation of one complex of [Cr(MeQ)2(H2O)2]Cl.3/2H2O. 
Ellipsoids drawn at 50%.  
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Figure 1b. Structural representation of the two complexes of  
[Cr(MeQ)2(H2O)2]Cl.3/2H2O. Ellipsoids drawn at 50%.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1c. Structural representation of the two complexes of 
[Cr(MeQ)2(H2O)2]Cl.3/2H2O. Ellipsoids drawn at 50% (hydrogen bonding and 
hydrogen atoms labelled). 
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Table 2. Selected bond lengths (Å) and bond angles (⁰) for [Cr(MeQ)2(H2O)2]Cl. 
Bond length (Å) 
Cr1-O11 1.923(3) Cr1-O41 1.986(3) 
Cr1-O1 1.944(3) Cr1-N11 2.096(4) 
Cr1-O42 1.980(3) Cr1-N1 2.100(4) 
Cr2-O31 1.941(3) Cr2-O43 1.978(3) 
Cr2-O21 1.918(3) Cr2-N31 2.092(4) 
Cr2-O44 2.000(3) Cr2-N21 2.109(4) 
Bond Angles (⁰) 
O11-Cr1-O1 172.45(14) O42-Cr1-N11 167.57(15) 
O11-Cr1-O42 85.62(14) O41-Cr1-N11 86.92(14) 
O1-Cr1-O42 89.00(13) O11-Cr1-N1 103.12(14) 
O11-Cr1-O41 91.12(13) O1-Cr1-N1 82.02(14) 
O1-Cr1-O41 84.11(13) O42-Cr1-N1 88.80(14) 
O42-Cr1-O41 95.42(14) O41-Cr1-N1 165.43(14) 
O11-Cr1-N11 82.13(15) N11-Cr1-N1 91.94(15) 
O1-Cr1-N11 103.39(15)   
O31-Cr2-O21 173.57(14) O44-Cr2-N31 167.01(14) 
O31-Cr2-O44 85.69(13) O43-Cr2-N31 91.10(14) 
O21-Cr2-O44 90.34(13) O31-Cr2-N21 102.70(15) 
O31-Cr2-O43 89.79(13) O21-Cr2-N21 82.07(15) 
O21-Cr2-O43 85.42(13) O44-Cr2-N21 86.66(14) 
O44-Cr2-O43 93.66(13) O43-Cr2-N21 167.49(15) 
O31-Cr2-N31 82.25(14) N31-Cr2-N21 91.29(15) 
O21-Cr2-N31 102.10(14)   
 
Crystal structure of [Cr(Q)(phen)2](PF6)2.MeCN 
Red crystals of [Cr(Q)(phen)2](PF6)2 were obtained by vapour diffusion of diethyl ether 
into an acetonitrile solution of the complex. The complex crystallises in the triclinic 
space group P-1 and contains a single complex within the asymmetric unit (Figure 2). 
Based on the bond angles about the metal centre which range from 79.89(5)-99.47(5)º 
and 168.44(5)-175.88(5)º, the geometry of the complex is best considered as slightly 
distorted N5O octahedral (Table 3). One of the PF6- counter ions is disordered over 
three positions, and one MeCN solvent of crystallization is observed in the structure. 
Four of the nitrogen donor atoms (N11, N12, N31 and N32) originate from the two 
phenanthroline molecules while the fifth and sixth coordinating atoms are the nitrogen 
and oxygen donor atoms, N1 and O1 from the quinolinato ligand. Relatively few Cr(III) 
compounds with a N5O donor set have been crystallographically characterised,16 but 
this is a rare example of quinolinato derivative to be crystallographically characterized 
as part of a N5O coordination sphere around a Cr(III) centre. The Cr-N and Cr-O bond 
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lengths are similar to [Cr(MeQ)2(H2O)2]Cl and range from 2.0495(14)-2.0729(13) Å for 
the Cr-N bonds and is 1.9059(11) Å for the Cr-O bond.  
 
  
 
 
 
 
 
 
 
 
Figure 2: Structural representation of complex [Cr(Q)(phen)2](PF6)2.MeCN. Ellipsoids 
drawn at 50% (PF6 anions and solvent MeCN omitted). 
 
Table 3. Selected bond lengths (Å) and bond angles (⁰) for [Cr(Q)(phen)2](PF6)2. 
Bond length (Å) 
Cr1-O1 1.9059(11) Cr1-N32 2.0497(13) 
Cr1-N1 2.0475(13) Cr1-N12 2.0701(14) 
Cr1-N11 2.0495(14) Cr1-N31 2.0729(13) 
Bond Angles (⁰) 
O1-Cr1-N1 83.20(5) N11-Cr1-N12 80.64(5) 
O1-Cr1-N11 89.18(5) N32-Cr1-N12 175.88(5) 
N1-Cr1-N11 168.44(7) O1-Cr1-N31 169.85(5) 
O1-Cr1-N32 91.20(5) N1-Cr1-N31 92.43(5) 
N1-Cr1-N32 93.48(5) N11-Cr1-N31 96.44(5) 
N11-Cr1-N32 95.37(5) N32-Cr1-N31 79.89(5) 
O1-Cr1-N12 89.76(5) N12-Cr1-N31 99.47(5) 
N1-Cr1-N12 90.62(5)   
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Crystal structures of [Cr(MeQ)(bipy)2](PF6)2.H2O and [Cr(NO2Q)(bipy)2](PF6)2.2 
MeCN     
Red crystals of [Cr(MeQ)(bipy)2](PF6)2 were obtained by vapour diffusion of diethyl 
ether into an acetonitrile solution of the complex. The complex crystallises in the 
monoclinic space group P21/n and contains a single complex and one water molecule 
of crystallization within the asymmetric unit (Figure 3). Similar to [Cr(Q)(phen)2](PF6)2, 
the Cr(III) ion is surrounded by five nitrogen and one oxygen atoms within the 
coordination sphere, with two PF6- counter ions within the lattice framework. The two 
bipyridine ligands coordinate through N11, N12, N21 and N22 while the fifth and sixth 
coordinating atoms are N1 and O1 from MeQ ligand. Again, [Cr(MeQ)(bipy)2](PF6)2 
shows a slightly distorted octahedral geometry which is very similar to 
[Cr(Q)(phen)2](PF6)2.  
 [Cr(NO2Q)(bipy)2](PF6)2 crystallises in the P-1 space group and the structure 
reveals two MeCN solvent molecules of crystallization. One of the PF6- counter ions is 
disordered. The structure is analogous to [Cr(MeQ)(bipy)2](PF6)2 with only very minor 
deviations in the bond lengths describing the coordination sphere. These observations 
suggest that the nature of the substituent on the quinolinato ligand (electron donating 
methyl versus electron withdrawing nitro) has little influence upon the strength of the 
metal ligand bonding.  
 
 
 
 
 
 
 
Figure 3. Structural representations of complex [Cr(MeQ)(bipy)2](PF6)2 (left) and 
[Cr(NO2Q)(bipy)2](PF6)2. Ellipsoids drawn at 50% (PF6 anions and solvent omitted). 
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Table 4. Selected bond lengths (Å) and bond angles (⁰) for [Cr(MeQ)(bipy)2](PF6)2. 
Bond length (Å) 
Cr1-O1 1.9084(15) Cr1-N22 2.0794(18) 
Cr1-N21 2.0533(18) Cr1-N11 2.0822(18) 
Cr1-N12 2.0626(19) Cr1-N1 2.0916(18) 
Bond Angles (⁰) 
O1-Cr1-N21 88.36(7) N12-Cr1-N11 78.16(8) 
O1-Cr1-N12 92.25(7) N22-Cr1-N11 96.23(7) 
N21-Cr1-N12 96.71(7) O1-Cr1-N1 83.22(7) 
O1-Cr1-N22 92.94(7) N21-Cr1-N1 166.78(7) 
N21-Cr1-N22 79.26(7) N12-Cr1-N1 93.80(7) 
N12-Cr1-N22 173.33(7) N22-Cr1-N1 90.97(7) 
O1-Cr1-N11 168.82(7) N11-Cr1-N1 102.95(7) 
N21-Cr1-N11 87.08(7)   
 
Table 4: Selected bond lengths (Å) and bond angles (⁰) for [Cr(NO2Q)(bipy)2](PF6)2. 
Bond length (Å) 
Cr1-O1 1.917(2) Cr1-N12 2.046(3) 
Cr1-N1 2.039(2) Cr1-N21 2.048(3) 
Cr1-N22 2.048(2) Cr1-N11 2.062(3) 
Bond Angles (⁰) 
O1-Cr1-N1 82.23(10) N22-Cr1-N12 173.38(10) 
O1-Cr1-N22 89.70(10) N22-Cr1-N21 79.46(10) 
N1-Cr1-N22 97.17(10) O1-Cr1-N21 95.42(10) 
O1-Cr1-N12 94.22(10) N1-Cr1-N21 175.93(10) 
N1-Cr1-N12 88.65(10) N12-Cr1-N21 94.84(10) 
N12-Cr1-N11 79.03(11) N22-Cr1-N11 97.39(10) 
O1-Cr1-N11 172.23(10) N11-Cr1-N1 93.69(10) 
N21-Cr1-N11 89.03(10)   
 
 
General characterisation of the Cr(III) complexes 
A range of analytical and spectroscopic techniques were used to characterize the 
complexes. IR spectra of the Cr(III) complexes were recorded over the range 4000–
400 cm−1 and selected bands are presented in the experimental section and confirm 
the presence of the ligand in each case. The IR spectra of the bis aquo Cr(III) 
complexes show the presence of O-H vibrations which are attributed to the 
hygroscopic nature of these species and the coordinated water molecules. The 
spectra for the [Cr(Q)(N^N)2](PF6)2 complexes also showed the presence of the 
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hexafluorophosphate counter anion ca. 835 cm-1. Mass spectrometry data was 
obtained for all complexes generally showing the parent ion or a cationic fragment with 
isotopic distributions consistent with the presence of chromium.  Satisfactory 
elemental analyses were obtained for each complex, with the bis aquo complexes, in 
particular, showing the presence of additional water. This reflects the likely 
hygroscopic nature of these complexes and is consistent with the IR data and crystal 
structure of [Cr(MeQ)2(H2O)2]Cl.3/2H2O. 
 
Electrochemical studies 
The electrochemical data for the Cr(III) complexes were obtained in acetonitrile using 
[Bu4N][PF6] (0.1 M) as the supporting electrolyte. The data is tabulated for all Cr(III) 
complexes in Table 5 and focused upon the reduction processes (no oxidative 
processes were clearly observed in the solvent window). The cyclic voltammograms 
of these complexes are very similar, showing two reduction processes in the regions 
-1.34 to -1.66 V and -1.91 to -2.17 V (versus Fc/Fc+). The first of these reductions was 
deduced to be reversible with peak to peak separations 59-72 mV. Furthermore, the 
ratio of ipc to ipa is ~1 supporting the reversible nature of these processes. From the 
data, the reduction potentials for the NO2Q derivatives were more positive relative to 
the unsubstituted analogues; the methyl-substituted complexes were at more negative 
potentials. This pattern is consistent with the anticipated electron donating or 
withdrawing capacities of these different substituents. Monzon et al. have investigated 
the electrochemical potentials for [Cr(Q)3] and reported two reversible peaks at -1.54 
and -2.03 V (vs Fc/Fc+) which they attribute to the Cr(III)/Cr(II) couple and the 
quinolinato ligand system, respectively.17 Our own measurements compare favorably 
with those reported, and the other complexes in the series follow a similar pattern. 
Therefore the first reduction potential at -1.34 to -1.66 V may be due to a metal-centred 
process (forming low spin Cr(II).18 The second potential at -1.91 to -2.17 V is attributed 
to a ligand-centred reduction although it is unclear for the mixed ligand complexes 
whether this can attributed solely to the quinolinato ligands.  
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Electronic properties of the complexes 
The magnetic moments (μeff) of the Cr(III) complexes were measured using the Evans’ 
method19 in DMSO solvent at room temperature. The obtained values of 3.73-4.08 
B.M. (see Experimental section) are consistent with the d3 configuration of Cr(III).  
The electronic spectra of the Cr(III) complexes were measured in DMF solutions and 
their spectral data are tabulated in Table 5. Taking the tris quinolinate complex [Cr(Q)3] 
as a reference, the spectrum displayed the expected bands that have been noted 
previously.20 Thus, ligand centred bands were noted at 319 and 413 nm, each being 
attributed to transitions with π→π* character. The 413 nm band was bathochromically 
shifted relative to free 8-hydroxyquinoline. In addition to these bands, a much weaker 
intensity longer wavelength band, often visible as a shoulder feature in these 
complexes, was noted at approximately 546 nm (e » 100 M-1cm-1) and assigned to the 
metal-centred d-d transition 4A2→4T2, again in broad agreement with previous work.21  
 Replacing one of the 8-quinolinato ligands with two water molecules 
([Cr(Q)2(H2O)2]Cl) resulted in comparable ligand centred transitions and a general 
lowering of the 4A2→4T2 transition energy, the latter probably reflecting the overall 
weakening of the ligand field at Cr(III). The remaining mixed ligand 
[Cr(Q)(N^N)2](PF6)2 complexes again showed similar spectral features, but with 
additional contributions at higher energy that can be assigned to the π→π* transitions 
within the bipy/phen ligands. This is consistent with the numerous reports on 
polypyridine complexes of Cr(III).22 It should also be noted that in Cr(III) polypyridyl 
complexes, ligand-to-metal charge transfer (LMCT) bands are also known to 
contribute in the UV region. Again, for [Cr(Q)(N^N)2](PF6)2 the weak 4A2→4T2 transition 
was observable between 507-545 nm in all cases, with the highest energy noted for 
[Cr(Q)(phen)2](PF6)2 which is consistent with a strong ligand field at Cr(III).  
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Table 5: Electronic properties of the Cr(III) complexes in solution. 
 
Complex Absorption,  
λmax / nm a 
Emission,  
λem / nmb 
Reduction potentials, 
E1/2 / Vc 
     *π→π d-d    
[Cr(Q)3] 319, 413  546  500 -1.56 -2.07 
[Cr(MeQ)3] 308, 404 579  511 -1.66 -2.17 
[Cr(NO2Q)3] 333, 408 529  476 -1.42 -1.95 
[Cr(Q)2(H2O)2]Cl 315, 403 565  495 -1.48 -2.02 
[Cr(MeQ)2(H2O)2]Cl 291, 402 563  504 -1.64 -2.14 
[Cr(NO2Q)2(H2O)2]Cl 332, 427 594  463 -1.39 -1.92 
[Cr(Q)(phen)2](PF6)2 273, 366 507  500 -1.46 -2.06 
[Cr(MeQ)(phen)2](PF6)2 276, 374 515  507 -1.57 -2.12 
[Cr(NO2Q)(phen)2](PF6)2 271, 385 531  492 -1.34 -1.91 
[Cr(Q)(bipy)2](PF6)2 304, 386 545  484 -1.43 -2.02 
[Cr(MeQ)(bipy)2](PF6)2 305, 441 533  493 -1.57 -2.10 
[Cr(NO2Q)(bipy)2](PF6)2 306, 399 533  472 (vw) -1.37 -1.93 
  a DMF solution; b aerated MeCN solution; c deoxygenated MeCN solution, 0.1 M [Bu4N][PF6] 
supporting electrolyte, measured at 100 mV/s. Potential versus Fc/Fc+. 
 
 
Figure 4. Absorption spectra of [Cr(Q)3] (left) and [Cr(Q)2(H2O)2]Cl (right). 
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Figure 5. Absorption spectra of [Cr(Q)(bipy)2](PF6)2 (left) and [Cr(MeQ)(bipy)2](PF6)2 
(right) with 4A2→4T2 transition shown (inset). 
 
 
 
 
 
 
 
 
 
 
Figure 6. Steady state emission (red) and excitation (blue) spectra (MeCN) for [Cr(Q)3] 
(top left), [Cr(MeQ)3] (top right), [Cr(MeQ)2(H2O)2]Cl (bottom left) and 
[Cr(MeQ)(bipy)2](PF6)2 (bottom right). 
 
Luminescence studies of the complexes were undertaken on aerated MeCN solutions 
at room temperature (Figure 6). Previous studies have described [Cr(Q)3] as non-
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luminescent or very weakly emissive at room temperature.20 However, in solution 
following irradiation at 380 nm, which corresponds to excitation of the ligand-centred 
transitions, we observed an emission band at 500 nm (Figure 6). This recorded 
emission wavelength for [Cr(Q)3] compares quite well to the green fluorescence 
character often attributed to oxine complexes of Al(III)23 and Zn(II).24  
 Substituting the quinolinato ligand subtly modulated these spectral features, 
presumably due to the change in the electronics of the coordinated ligand. For 
example, [Cr(NO2Q)3] gave a hypsochromic shift in the emission band to 476 nm. The 
related bis aquo complexes retained the luminescence character, with emission in the 
range 463-504 nm which is again indicative of a quinolinato-centred fluorescence. The 
appearance of the excitation spectra for these species was very closely related to the 
tris-quinolinato species (Figure 6). Further solvent studies on the bis aquo complexes 
showed that the emission character was retained in aqueous solution.  
 Finally, for the [Cr(Q)(N^N)2](PF6)2 complexes, similar luminescence properties 
were again observed with a broad peak around 500 nm, and thus comparable to the 
other complexes in this study. These species produced markedly different excitation 
spectra with a much more intense peak at shorter wavelengths (ca. 365 nm), which 
may relate to transitions within the coordinated diimine ligands. For these Cr(III) 
complexes, there was no evidence of any metal-centred phosphorescence peaks in 
the typical range 700-800 nm at room temperature.25 
 
Conclusion 
8-hydroxyquinoline complexes of Cr(III) can be prepared to give six coordinate 
homoleptic or heteroleptic species. In all cases the complexes are highly coloured and 
demonstrated luminescence in the visible region, which was attributed to ligand-
centred excited states. The electronic properties can be subtly modulated through 
substituents on the 8-quinolinato ligand; these observations were further supported by 
electrochemical properties. Four structural examples were determined with X-ray data 
revealing octahedral species in each case. For the bis aquo complex the structure 
confirmed the mutually cis arrangement of the coordinated water molecules.  
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Experimental 
General Experimental Considerations 
All reagents and solvents were commercially available and were used without further 
purification if not stated otherwise. Petroleum ether refers to the 40-60 °C fraction. 
Low-resolution mass spectra were obtained by the staff at Cardiff University. High-
resolution mass spectra were carried out at the EPSRC National Mass Spectrometry 
Facility at Swansea University. High resolution mass spectral (HRMS) data were 
obtained on a Waters MALDI-TOF mx at Cardiff University or on a Thermo Scientific 
LTQ Orbitrap XL by the EPSRC UK National Mass Spectrometry Facility at Swansea 
University. IR spectra were obtained from a Shimadzu IR-Affinity-1S FTIR and melting 
points using a Gallenkamp apparatus and are reported uncorrected. Reference to 
spectroscopic data are given for known compounds. UV-Vis studies were performed 
on a Jasco V-570 spectrophotometer as MeCN solutions (2.5 or 5 × 10-5 M). 
Photophysical data were obtained on a JobinYvon–Horiba Fluorolog spectrometer 
fitted with a JY TBX picosecond photodetection module as MeCN solutions. Emission 
spectra were uncorrected and excitation spectra were instrument corrected. The 
pulsed source was a Nano-LED configured for 459 nm output operating at 1 MHz. 
Luminescence lifetime profiles were obtained using the JobinYvon–Horiba FluoroHub 
single photon counting module and the data fits yielded the lifetime values using the 
provided DAS6 deconvolution software.  
 
X-ray Diffraction  
For the four samples (for reference see Table 1), a suitable crystal26  was selected and 
mounted on a MITIGEN holder in oil on a Rigaku FRE+ (45.0 kV, 55.0 mA) equipped 
with either VHF Varimax confocal mirrors (70µm focus) (2, 3) or HF Varimax confocal 
mirrors (100µm focus) (1, 4) and an AFC12 goniometer with HG Saturn 724+ detector 
([HL3]PF6). The crystals were kept at T = 100(2) K during data collection. Data were 
measured using profile data from ω-scans using MoKα radiation. Cell determination 
and data collection were carried out using CrystalClear27,  with the data reduction, cell 
refinement and absorption correction using CrystalisPro28.CrystalisPro. Using Olex229, 
the structures were solved with the ShelXT30  structure solution program and the 
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models were refined with version 2018/3 of ShelXL 31 using Least Squares 
minimisation. All non-hydrogen atoms were refined anisotropically. Hydrogen atom 
positions were calculated geometrically and refined using the riding model. 1 was 
solved as a non-merohedral twin (62:38) with 180° rotation about direct axis (0.71 -
0.70 0). The other samples each have a disordered PF6 anion resulting in the use of 
geometrical (SADI) and displacement (RIGU) restraints (3 also has a disordered water 
molecule).   
CCDC1865072-1865075 contains the supplementary crystallographic data for this 
paper. These data can be obtained free of charge from the Cambridge 
Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif. 
 
Synthesis of [Cr(Q)3] 
The general method was to use a solution of CrCl3.6H2O (1 eq.) in 5 cm3 water which 
was poured into the solution of the appropriate 8-hydroxyquinoline (either 2 or 3 eq.) 
in 15 cm3 ethanol. The mixture was heated to reflux for 3 hours. The solution then 
changed from green to brown. After this time, the mixture solution was concentrated 
to 5 ml. The formed precipitate was filtered, washed with acetone 20 cm3 and ether 10 
cm3 and then dried under vacuum. For [Cr(Q)3], 8-hydroxyquinoline (0.83 g, 5.7  mmol)  
and CrCl3.6H2O (0.5 g, 1.9 mmol) were used giving the product as a green powder. 
Yield: 0.87 g, 80%. ESI-MS (m/z): 484.08 [M+]; HRMS found m/z 484.0754, calc. 
mass: 484.0753. Selected FT-IR (cm-1): ѵ(C=N) 1570, ѵ(C-O) 1110. UV-vis. λmax (εM, 
M-1cm-1): 319 (5400), 413 (3500) and 546 (110) nm. Elemental Analysis: calcd. for 
C27H18CrN3O3.CH3CH2OH  (%): C, 65.66; H, 4.56; N, 7.92; found (%): C, 65.25; H, 
4.88; N, 7.96. Magnetic moment μobs (B.M.): 3.863. 
 
Synthesis of [Cr(MeQ)3]     
Using 8-hydroxy-2-methylquinoline (0.91 g, 5.7 mmol) and CrCl3.6H2O (0.5 g, 1.9 
mmol) giving the product as a green powder. Yield: 0.95 g, 80%. ESI-MS (m/z): 526.12 
[M+]; HRMS found m/z 526.1223, calc. mass: 526.1223. Selected FT-IR (cm-1): 
ѵ(C=N) 1550, ѵ(C-O) 1107. UV-vis., λmax (ε, M-1cm-1): 308 (3900), 404 (2500) and 579 
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(40) nm. Elemental analysis. calcd. for C30H24CrN3O3.3H2O (%): C, 62.06; H, 5.21; N, 
7.24; found (%): C, 62.41; H, 5.05; N, 7.50. Magnetic moment μobs (B.M.): 3.731. 
Synthesis of [Cr(NO2Q)3] 
Using 8-hydroxy-5-nitroquinoline (1.08 g, 5.7 mmol) and CrCl3.6H2O (0.5 g, 1.9 mmol) 
giving the product as a brown powder. Yield: 1.05 g, 74%. ESI-MS (m/z): 618.95 [M+]; 
HRMS found m/z 619.0296; calc. mass 619.0306. Selected FT-IR (cm-1): ѵ(C=N) 
1570, ѵ(C-O) 1099. UV-vis., λmax (ε, M-1cm-1): 333 (7300), 408 (2300) and 529 (390) 
nm. Elemental analysis: calcd. for C27H15CrN6O9 (%): C, 52.35; H, 2.44; N,13.57; found 
(%): C, 52.28; H, 2.57; N, 13.49. Magnetic moment μobs (B.M.): 3.825. 
 
Synthesis of [Cr(Q)2(H2O)2]Cl 
Using CrCl3.6H2O (0.5 g, 1.9 mmol) and 8-hydroxyquinoline (0.545 g, 3.8 mmol) giving 
a brown powder. Yield (0.38 g, 71 %). ESI-MS (m/z): 376.06 [M+]; HRMS found m/z 
376.0753; calc. 376.0761. Selected FT-IR (cm-1): ѵ(O-H) 3420, ѵ(O-H) 1377, ѵ(C=N) 
1554, ѵ(C-O) 1109.  UV-vis., λmax (ε, M-1 cm-1): 315 (2400), 403 (1800) and 565 (80) 
nm. Elemental analysis: calcd. for C18H16ClCrN2O4.2H2O (%): C,48.28; H, 4.50; N, 
6.26; found (%): C, 48.95; H, 4.86; N, 6.39. Magnetic moment μobs (B.M.): 3.785. 
 
Synthesis of [Cr(MeQ)2(H2O)2]Cl     
Using 8-hydroxy-2-methylquinoline (0.6 g, 3.8 mmol) and CrCl3.6H2O (0.5 g, 1.9 
mmol) giving the product as dark green crystals. Yield: 0.41 g, 69%. ESI-MS (m/z): 
404.08 [M+]; HRMS found m/z 404.0903; calc. mass: 404.0884. Selected FT-IR (cm-
1): ѵ(O-H) 3428, ѵ(O-H) 1369, ѵ(C=N) 1541, ѵ(C-O) 1105. UV-vis., λmax (ε, M-1 cm-1): 
291 (1300), 402 (470) and 563 (40) nm. C20H20ClCrN2O4.H2O.CH3CH2OH (%): C, 
52.44; H, 5.60; N, 5.56; found (%): C, 53.04; H, 6.03; N, 5.68.  Magnetic moment μobs 
(B.M.): 3.839. 
Synthesis of [Cr(NO2Q)2(H2O)2]Cl     
Using 8-hydroxy-5-nitroquinoline (0.71 g, 3.8 mmol) and CrCl3.6H2O (0.5 g,  1.9 mmol) 
giving the product as a brown powder. Yield: 0.56 g, 79%. ESI-MS (m/z): 504.00 
[M+K+]. Selected FT-IR (cm-1): ѵ(O-H) 3437, ѵ(O-H) 1380, ѵ(C=N) 1566, ѵ(C-O) 
1101. UV-vis., λmax (ε, M-1 cm-1): 332 (3200), 427 (1700) and 594 (120) nm. Elemental 
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analysis: calcd. for: C18H14ClCrN4O8 (%): C, 43.09; H, 2.81; N, 11.17; found (%): C, 
43.29; H, 3.15; N, 11.25. Magnetic moment μobs (B.M.): 3.813. 
Synthesis of [Cr(Q)(phen)2](PF6)2 
The starting material [Cr(phen)2Cl2]Cl and [Cr(phen)2(CF3SO3)2](CF3SO3) was 
prepared as described previously.27 [Cr(Q)(phen)2](PF6)2 was prepared by stirring at 
room temperature, the mixture solution of [Cr(phen)2(CF3SO3)2](CF3SO3) (0.5 g, 0.58 
mmol) in 10 cm3 MeCN and 8-hydroxyquinoline (0.085 g, 0.58 mmol) in 5 cm3 MeCN 
for 3 hours. Concentration of the dark red solution to 5 cm3, and then addition of KPF6 
(0.42 g, 2.3 mmol) in 2 cm3 H2O resulted in a brown precipitate which was stirrer for 
30 minutes. The brown precipitate was filtered, washed with 3 cm3 H2O and 2 cm3 
MeCN and then dried under vacuum. Red crystals of [Cr(Q)(phen)2](PF6)2 were 
obtained by vapor diffusion of diethyl ether into MeCN solution of the complex. Yield: 
0.32 g, 64%. ESI-MS (m/z): 578.03 [M+Na+]. Selected FT-IR (cm-1): ѵ(C=N) 1564, 
ѵ(C-O) 1107, ѵ(PF6-) 829. UV-vis., λmax (ε, M-1 cm-1): 273 (2700), 366 (1300) and 
507(40) nm. Elemental analysis: calcd. for C33H22CrF12N5OP2.4H2O (%): C, 43.15; H, 
3.29; N, 7.62; found (%): C, 43.05; H, 2.86; N, 7.49. Magnetic moment μobs (B.M.): 
4.038. 
Synthesis of [Cr(MeQ)(phen)2](PF6)2 
As for [Cr(Q)(phen)2](PF6)2 but using [Cr(phen)2(CF3SO3)2](CF3SO3) (0.5 g, 0.58 
mmol), 8-hydroxy-2-methylquinoline (0.093 g, 0.58 mmol) and KPF6 (0.42 g, 2.3 
mmol). Product was isolated as a brown powder. Yield: 0.34 g, 68%. ESI-MS (m/z): 
570.87 [M+]. Selected FT-IR (cm-1): ѵ(C=N) 1558, ѵ(C-O) 1104, ѵ(PF6-) 830. UV-vis. 
λmax (ε, M-1 cm-1): 276 (3400), 374 (1800) and 515 (45) nm. Elemental analysis: calcd. 
for C34H24CrF12N5OP2 (%): C, 47.46; H, 2.81; N, 8.14; found (%): C, 47.59; H, 2.98; N, 
8.05. Magnetic moment μobs (B.M.): 3.968. 
Synthesis of Cr(NO2Q)(phen)2](PF6)2 
Using [Cr(phen)2(CF3SO3)2](CF3SO3) (0.5 g, 0.58 mmol), 8-hydroxy-5-nitroquinoline 
(0.11 g, 0.58 mmol) and KPF6 (0.42 g, 2.3 mmol). Product was isolated as a brown 
solid. Yield: 0.3 g, 61%. ESI-MS (m/z): 601.03 [M+]; HRMS found m/z  601.0277; calc. 
mass: 601.0302. Selected FT-IR (cm-1): ѵ(C=N) 1581,  ѵ(C-O) 1116, ѵ(PF6-) 832. UV-
vis. λmax (ε, M-1 cm-1): 271 (2400), 385 (1700) and 531 (80) nm. Elemental analysis: 
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calcd. for C33H21CrF12N6O3P2 (%): C, 44.46; H, 2.37; N, 9.43; found (%): C, 44.58; H, 
2.47; N, 9.61. Magnetic moment μobs (B.M.): 4.075. 
Synthesis of [Cr(Q)(bipy)2](PF6)2 
The precursor materials [Cr(bpy)2Cl2]Cl and [Cr(bpy)2(CF3SO3)2](CF3SO3) were 
prepared as described previously. [Cr(Q)(bipy)2](PF6)2 was prepared by stirring at 
room temperature, the solution of [Cr(bpy)2(CF3SO3)2](CF3SO3) (0.5 g, 0.62 mmol) in 
10 cm3 MeCN and 8-hydroxyquinoline (0.089 g, 0.62 mmol) in 5 cm3 MeCN for 3 
hours. Concentration of the dark red solution to 5 cm3, and then addition of KPF6 (0.45 
g, 2.46 mmol) in 2 cm3 H2O gave a brown precipitate that was filtered, washed with 3 
cm3 H2O and 2 cm3 MeCN and then dried under vacuum to give a brown powder. 
Yield: 0.4 g, 80%. ESI-MS (m/z): 508.15 [M+]. Selected FT-IR (cm-1): ѵ(C=N) 1565, 
ѵ(C-O) 1115, ѵ(PF6-) 833; UV-vis. λmax (ε, M-1 cm-1): 304 (8400), 386 (810) and 
545(131) nm. Elemental analysis: calcd. for C29H22CrF12N5OP2.4H2O (%): C,40.01; H, 
3.47; N, 8.05; found (%): C, 40.59; H, 3.67; N, 8.17. Magnetic moment μobs (B.M.): 
4.000. 
 
Synthesis of [Cr(MeQ)(bipy)2](PF6)2  
Using [Cr(bpy)2(CF3SO3)2](CF3SO3) (0.5 g, 0.62 mmol), 8-hydroxy-2-methylquinoline 
(0.1 g, 0.62 mmol) and KPF6 (0.45 g, 2.46 mmol). Red crystals of 
[Cr(MeQ)(bipy)2](PF6)2 were obtained by vapour diffusion of diethyl ether into a 
concentrated MeCN solution of the complex. Yield: 0.33 g, 67%. ESI-MS (m/z): 545.13  
[M+Na+]. Selected FT-IR (cm-1): ѵ(C=N) 1560, ѵ(C-O) 1109, ѵ(PF6-) 835. UV-vis. λmax 
(ε, M-1 cm-1): 305 (4000), 441 (120) and 533 (50) nm. Elemental analysis: calcd. for 
C30H24CrF12N5OP2 (%): C, 44.35; H, 2.98; N, 8.62; found (%): C, 44.49; H, 3.10; N, 
8.84. Magnetic moment μobs (B.M.): 3.928. 
Synthesis of [Cr(NO2Q)(bipy)2](PF6)2  
Using [Cr(bpy)2(CF3SO3)2](CF3SO3) (0.5 g, 0.62 mmol), 8-hydroxy-5-nitroquinoline 
(0.12 g, 0.62 mmol) and KPF6 (0.46 g, 2.48 mmol). Red crystals of 
[Cr(NO2Q)(bipy)2](PF6)2 were obtained by vapour diffusion of diethyl ether into a 
concentrated MeCN solution of the complex. Yield: 0.29 g, 57%. ESI-MS (m/z): 553.03 
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[M+]; HRMS found m/z 554.1350; calc. mass: 554.1367. Selected FT-IR (cm-1): 
ѵ(C=N) 1575, ѵ(C-O) 1120, ѵ(PF6-) 837. UV-vis. λmax (ε, M-1 cm-1): 306 (1950), 399 
(980) and 533 (110). Elemental analysis: calcd. for C29H21CrF12N6O3P2.2H2O (%): C, 
39.61; H, 2.87; N, 9.56; found (%): C, 40.22; H, 3.23; N, 9.73. Magnetic moment μobs 
(B.M.): 3.890. 
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